Ammonium Chloride → 8-[3-(4-Diphenylmethylpiperazine-1-yl)-2-hydroxy-propoxy]isoquinoline
反応式
[OH:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[CH:10]=[N:9][CH:8]=[CH:7]2.ClCC(O)C[CH:16]1[NH:21][CH2:20][CH2:19][N:18]([CH:22]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[CH2:17]1.[CH3:36][C:37](C)([O-:39])[CH3:38].[K+].[Cl-].[NH4+]>C1COCC1.C(Cl)Cl>[C:29]1([CH:22]([C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[N:18]2[CH2:17][CH2:16][N:21]([CH2:36][CH:37]([OH:39])[CH2:38][O:1][C:2]3[CH:3]=[CH:4][CH:5]=[C:6]4[C:11]=3[CH:10]=[N:9][CH:8]=[CH:7]4)[CH2:20][CH2:19]2)[CH:30]=[CH:31][CH:32]=[CH:33][CH:34]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
In 15 ml of dried THF were dissolved 80 mg of 8-hydroxyisoquinoline and 204 mg of 4-(3-(chloro-2-hydroxypropyl)-1-diphenylmethylpiperazine synthesized in Example 23-(b), and 68 mg of potassium t-butoxide was further added thereto, followed by stirring at room temperature for 20 hours. The reaction liquid was then poured into 15 ml of an aqueous saturated ammonium chloride solution, and extraction was then performed with 150 ml of methylene chloride. After drying with an anhydrous Glauber's salt, the solvent was distilled off, and the resultant residue was purified through a silica gel thin-layer chromatograph. Development was carried out by the use of an effluent solvent of chloroform:methanol=25:1 for the purpose of separation and purification, with the result that 8-[3-(4-diphenylmethylpiperazine-1-yl)-2-hydroxy-propoxy]isoquinoline was obtained in an amount of 70 mg.
後処理
- additionwas further added
- customThe reaction liquid
- dry with materialAfter drying with an anhydrous Glauber's salt
- distillationthe solvent was distilled off
- customthe resultant residue was purified through a silica gel thin-layer chromatograph
- custommethanol=25:1 for the purpose of separation and purification
出典と根拠
- ORDレコード
- ord-2036fab978644b0683f23f3f01ace48f
- 出典データセット
- uspto-grants-1992_05
- 特許番号
- US05112817
反応ノート
読み込み中…